SPR Therapeutics Announces 20,000th Patient Implant of SPRINT® PNS System
Retrieved on:
Tuesday, August 22, 2023
Travel, Life, American Board of Preventive Medicine, SPR, Nurses Improving Care for Healthsystem Elders, Quality of life, PNS, Pain, American Board of Commissioners for Foreign Missions, Addiction medicine, Pain management, Patient, Data, Love, NorthShore University HealthSystem, Growth, Therapy, Chronic pain, SPRINT, Dentistry, Medical device, Pharmaceutical industry, MD
CLEVELAND, Aug. 22, 2023 (GLOBE NEWSWIRE) -- SPR® Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain, announced the 20,000th patient implant of the SPRINT® PNS System.
Key Points:
- CLEVELAND, Aug. 22, 2023 (GLOBE NEWSWIRE) -- SPR® Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain, announced the 20,000th patient implant of the SPRINT® PNS System.
- Since its commercialization six years ago in July 2017, many pain specialists have utilized the SPRINT PNS system as a new approach to offer their patients a less-invasive, 60-day treatment that does not require a permanent implant.
- The outcomes of real-world applications are a strong supplement to patient experience in clinical trials as the population is broader and more diverse.
- She also holds a board certification in Addiction Medicine from the American Board of Preventive Medicine and performed the very first commercial implant of the SPRINT PNS System in 2017 along with implanting the 20,000th patient.